Trexquant Investment LP trimmed its position in shares of Adient (NYSE:ADNT - Free Report) by 4.7% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 527,455 shares of the company's stock after selling 25,958 shares during the period. Trexquant Investment LP owned 0.63% of Adient worth $6,783,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Point72 Hong Kong Ltd purchased a new position in Adient during the 4th quarter worth approximately $25,000. Brooklyn Investment Group boosted its stake in shares of Adient by 23,600.0% during the 1st quarter. Brooklyn Investment Group now owns 2,133 shares of the company's stock valued at $27,000 after buying an additional 2,124 shares during the period. GAMMA Investing LLC boosted its stake in shares of Adient by 157.5% during the 1st quarter. GAMMA Investing LLC now owns 2,235 shares of the company's stock valued at $29,000 after buying an additional 1,367 shares during the period. CWM LLC boosted its stake in shares of Adient by 91.4% during the 1st quarter. CWM LLC now owns 3,426 shares of the company's stock valued at $44,000 after buying an additional 1,636 shares during the period. Finally, Caitong International Asset Management Co. Ltd boosted its stake in shares of Adient by 418.2% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 4,679 shares of the company's stock valued at $60,000 after buying an additional 3,776 shares during the period. 92.44% of the stock is currently owned by hedge funds and other institutional investors.
Adient Stock Performance
ADNT traded up $0.08 during trading on Thursday, hitting $24.34. The stock had a trading volume of 483,300 shares, compared to its average volume of 1,419,269. The firm has a market cap of $1.98 billion, a PE ratio of -9.16, a P/E/G ratio of 0.82 and a beta of 1.76. Adient has a 12 month low of $10.04 and a 12 month high of $25.84. The company has a current ratio of 1.12, a quick ratio of 0.92 and a debt-to-equity ratio of 1.15. The company has a 50 day simple moving average of $22.75 and a 200-day simple moving average of $17.44.
Adient (NYSE:ADNT - Get Free Report) last announced its earnings results on Wednesday, August 6th. The company reported $0.45 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.02). Adient had a positive return on equity of 8.25% and a negative net margin of 1.53%.The firm had revenue of $3.74 billion during the quarter, compared to the consensus estimate of $3.56 billion. During the same quarter last year, the business earned $0.32 EPS. The business's revenue was up .7% compared to the same quarter last year. Analysts expect that Adient will post 1.76 EPS for the current year.
Analyst Upgrades and Downgrades
ADNT has been the subject of a number of research reports. Zacks Research lowered shares of Adient from a "strong-buy" rating to a "hold" rating in a research note on Monday, August 18th. Bank of America lifted their target price on shares of Adient from $15.00 to $17.50 and gave the company an "underperform" rating in a research note on Monday, June 16th. Stifel Nicolaus started coverage on shares of Adient in a research note on Thursday, August 21st. They issued a "buy" rating and a $27.00 price objective for the company. Morgan Stanley lifted their price objective on shares of Adient from $16.00 to $17.00 and gave the company an "underweight" rating in a research note on Tuesday, August 12th. Finally, Cfra Research raised shares of Adient from a "moderate sell" rating to a "hold" rating in a research note on Thursday, August 7th. One equities research analyst has rated the stock with a Buy rating, nine have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the stock has an average rating of "Reduce" and an average target price of $21.72.
Get Our Latest Stock Report on Adient
Adient Profile
(
Free Report)
Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.
See Also

Before you consider Adient, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Adient wasn't on the list.
While Adient currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.